Urologia fundamental
LEITURA RECOMENDADA 1. Roehrborn CG, McConnell JD. Etiology, pathophisiology, epidemiology and natural history of BPH. In: Walsh PC, Retik AB, Vaughan Jr ED , Wein AJ (eds). Campbell’s Urology. 9.ed. Philadelphia: WB Saunders; 2007. p.2727-44. 2. Bushman W. Etiology, epidemiology, and natural history. Urol Clin N Am. 2009;36:403-15. 3. Emberton M, Fitzpatrick JM, Garcia-Losa M, Qizilbash N, Djavan B. Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials. BJU Int. 2008;102(8):981-6. 4. Mundy AR. The prostate and benign prostatic hiperplasia. In: Mundy AR, Fitzpatrick JM, Neal DE, George NJR (eds). The scientific basis of urology. Oxford: Isis Medical Media; 1999. p.257-73. 5. Committee APG. AUA guideline on management of benign prostatic hyperplasia. Diagnosis and treatment recommendations. J Urol. 2003;170:530-47.
204
6. Hering F, et al. Diretrizes em Hiperplasia Prostática Benigna. SBU e AMB 2009. 7. Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT and ALF-ONE. BJU Int. 2008;3:17-21. 8. De la Rosette J, Alivizatos G, Madersbacher S, Rioja-Sanz C, Nordling J, Emberton M, et al. EAU guidelines on benign prostatic hyperplasia. Disponível em: http://www. uroweb. org/fileadmin/tx_eauguidelines/2004/Full/BPH_2004.pdf. Acesso em: maio de 2010. 9. Rodrigues AO. Tratamento cirúrgico da hiperplasia prostática benigna. In: Wroclawsky ER, Bendhack DA, Damião R, OrtizV (eds). Guia prático de urologia. São Paulo: Segmento; 2003. p.287-8. 10. Kirby R, Lepor H. Evaluation and nonsurgical management of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan Jr ED , Wein AJ (eds). Campbell’s Urology. 9. ed. Philadelphia: WB Saunders; 2007. p.2773-801.